References
- Abe, K., et al., 2015. Effects of the PEG molecular weight of a PEG-lipid and cholesterol on PEG chain flexibility on liposome surfaces. Colloids and surfaces A: physicochemical and engineering aspects, 474, 63–70.
- Aldosari B.N., Alfagih I.M., and Almurshedi A.S., 2021. Lipid nanoparticles as delivery systems for RNA-based vaccines. Pharmaceutics, 13 (26), 206.
- Aloi, E., et al., 2020. Binding of warfarin differently affects the thermal behavior and chain packing of anionic, zwitterionic and cationic lipid membranes. Archives of biochemistry and biophysics, 694, 108599–10.
- Barui, A.K., et al., 2020. Cancer-targeted nanomedicine: overcoming the barrier of the protein corona. Advanced therapeutics, 3 (1), 1900116–1900124.
- Bedu-Addo, F.K., and Huang, L., 1995. Interaction of PEG-phospholipid conjugates with phospholipid: implications in liposomal drug delivery. Advanced drug delivery reviews, 16 (2–3), 235–247.
- Bedu-Addo, F.K., et al., 1996. Effects of polyethyleneglycol chain length and phospholipid acyl chain composition on the interaction of polyethyleneglycol-phospholipid conjugates with phospholipid: implications in liposomal drug delivery. Pharmaceutical research, 13 (5), 710–717.
- Belsito, S., Bartucci, R., and Sportelli, L., 1998. Sterically stabilized liposomes of DPPC/DPPE-PEG:2000. A spin label ESR and spectrophotometric study. Biophysical chemistry, 75 (1), 33–43.
- Beltrán-Gracia, Ε., et al., 2019. Nanomedicine review: clinical developments in liposomal applications. Cancer nanotechnology, 10 (1), 1–40.
- Benne, N., et al., 2018. Anionic 1,2-distearoyl-sn-glycero-3-phosphoglycerol (DSPG) liposomes induce antigen-specific regulatory T cells and prevent atherosclerosis in mice. Journal of controlled release, 291, 135–146.
- Binder, W.H., Barragan, V., and Menger, F.M., 2003. Domains and rafts in lipid membranes. Angewandte chemie, 42 (47), 5802–5827.
- Bonte, F., and Juliano, R.L., 1986. Interactions of liposomes with serum proteins. Chemistry and physics of lipids, 40 (2–4), 359–372.
- Bulbake, U., et al., 2017. Liposomal formulations in clinical use: an updated review. Pharmaceutics, 9 (4), 12–33.
- Capriotti, A.L., et al., 2012. Do plasma proteins distinguish between liposomes of varying charge density? Journal of proteomics, 75 (6), 1924–1932.
- Caracciolo, G., et al., 2013. Effect of DOPE and cholesterol on the protein adsorption onto lipid nanoparticles. Journal of nanoparticle research, 15 (3), 1491–1498.
- Caracciolo, G., et al., 2015. Lipid composition: a “key factor” for the rational manipulation of the liposome-protein corona by liposome design. RSC advances, 5 (8), 5967–5975.
- Chakraborty, D., Ethiraj, K.R., and Mukherjee, A., 2020. Understanding the relevance of protein corona in nanoparticle-based therapeutics and diagnostics. RSC advances, 10 (45), 27161–27172.
- Chiu, M.H., and Prenner, E.J., 2011. Differential scanning calorimetry: an invaluable tool for a detailed thermodynamic characterization of macromolecules and their interactions. Journal of pharmacy & bioallied sciences, 3 (1), 39–59.
- Demetzos, C., 2008. Differential scanning calorimetry (DSC): a tool to study the thermal behavior of lipid bilayers and liposomal stability. Journal of liposome research, 18 (3), 159–173.
- Demetzos, C., 2014. Pharmaceutical nanotechnology basics and applications. Athens: Parisianou.
- Digiacomo, L., et al., 2020. Impact of the protein corona on nanomaterial immune response and targeting ability. WIREs nanomedicine and nanobiotechnology, 12 (4), 1–15.
- Dos Santos, N., et al., 2007. Influence of poly(ethylene glycol) grafting density and polymer length on liposomes: relating plasma circulation lifetimes to protein binding. Biochimica et biophysica acta, 1768 (6), 1367–1377.
- Du, H., Chandaroy, P., and Hui, S.W., 1997. Grafted poly- ethylene glycol on lipid surfaces inhibits protein adsorption and cell adhesion. Biochimica et biophysica acta, 1326 (2), 236–248.
- Gaspar, R., Coelho, F., and Silva, B.F.B., 2020. Lipid-nucleic acid complexes: physicochemical aspects and prospects for cancer treatment. Molecules, 25 (21), 5006–5039.
- Giulimondi, F., et al., 2019. Interplay of protein corona and immune cells controls blood residency of liposomes. Nature communications, 10 (1), 3611–3686.
- Hatziantoniou, S., and Demetzos, C., 2008. Lipids of membranes: chemistry, biological role, and applications as drug carriers. Studies in natural products chemistry, 34, 173–202.
- Heuts, J., et al., 2021. Cationic nanoparticle-based cancer vaccines. Pharmaceutics, 13 (5), 519–596.
- Hou, X., et al., 2021. Lipid nanoparticles for mRNA delivery. Nature reviews. materials, 6 (12), 1078–1094.
- Hristova, K., Kenworthy, A., and McIntosh, T.J., 1995. Effect of bilayer composition on the phase behavior of liposomal suspensions containing poly(ethy1ene glycol)-lipids. Macromolecules, 28 (23), 7693–7699.
- Huang, C-h., and Li, S., 1999. Calorimetric and molecular mechanics studies of the thermotropic phase behavior of membrane phospholipids. Biochimica et biophysica acta, 1422 (3), 273–307.
- Immordino, M.L., Dosio, F., and Cattel, L., 2006. Stealth liposomes: review of the basic science, rationale, and clinical applications, existing and potential. International journal of nanomedicine, 1 (3), 297–315.
- Kenworthy, A.K., et al., 1995. Range and magnitude of the steric pressure between bilayers containing phospholipids with covalently attached poly(ethylene glycol). Biophysical journal, 68 (5), 1921–1936.
- Klein, M.E., et al., 2021. Towards the development of long circulating phosphatidylserine (PS)- and phosphatidylglycerol (PG)-enriched anti-inflammatory liposomes: is pegylation effective? Pharmaceutics, 13 (2), 216–282.
- Koynova, R., and Caffrey, M., 1998. Phases and phase transitions of the phosphatidylcholines. Biochimica et biophysica acta, 1376 (1), 91–145.
- Kristensen, K., et al., 2019. The hard protein corona of stealth liposomes is sparse. Journal of controlled release, 307, 1–15.
- Lee, A.G., 1977. Lipid phase transitions and phase diagrams. I. Lipid phase transitions. Biochimica et biophysica acta, 472 (2), 237–281.
- Lee, H., and Larson, R.G., 2016. Adsorption of plasma proteins onto PEGylated lipid bilayers: the effect of PEG size and grafting density. Biomacromolecules, 17 (5), 1757–1765.
- Lewis, R.N.A.H., Mak, N., and McElhaney, N.R., 1987. A differential scanning calorimetric study of the thermotropic phase behavior of model membranes composed of phosphatidylcholines containing linear saturated fatty acyl chains. Biochemistry, 26 (19), 6118–6126.
- Li, J., et al., 2015. A review on phospholipids and their main applications in drug delivery systems. Asian Journal of pharmaceutical sciences, 10 (2), 81–98.
- Lian, T., and Ho, R.J.Y., 2001. Minireview: trends and developments in liposome drug delivery systems. Journal of pharmaceutical sciences, 90 (6), 667–680.
- Lin, Q., et al., 2014. Lipid-based nanoparticles in the systemic delivery of siRNA. Nanomedicine, 9 (1), 105–120.
- Liu, C., et al., 2020. Barriers and strategies of cationic liposomes for cancer gene therapy. Molecular therapy. Methods & clinical development, 18, 751–764.
- Lynch, I., et al., 2007. The nanoparticle-protein complex as a biological entity; a complex fluids and surface science challenge for the 21st century. Advances in colloid and interface science, 134–135, 167–174.
- Marzban, E., et al., 2015. Optimizing the therapeutic efficacy of cisplatin PEGylated liposomes via incorporation of different DPPG ratios: in vitro and in vivo studies. Colloids and surfaces. B, biointerfaces, 136, 885–891.
- Matsingou, C., and Demetzos, C., 2007. Effect of the nature of the 3beta-substitution in manoyl oxides on the thermotropic behavior of DPPC lipid bilayer and on DPPC liposomes. Journal of liposome research, 17 (2), 89–105.
- Montesano, G., et al., 2001. Lipid membrane expansion and micelle formation by polymer-grafted lipids: scaling with polymer length studied by spin-label electron spin resonance. Biophysical journal, 80 (3), 1372–1383.
- Montizaan, D., et al., 2020. Comparison of the uptake mechanisms of zwitterionic and negatively charged liposomes by HeLa cells. Nanomedicine: nanotechnology, biology, and medicine, 30, 102300–10.
- Onishchenko, N., Tretiakova, D., and Vodovozova, E., 2021. Spotlight on the protein corona of liposomes. Acta biomaterialia,134:57–78.
- Papageorgiou, F., et al., 2019. Physicochemical study of the protein–liposome interactions: influence of liposome composition and concentration on protein binding. Journal of liposome research, 29 (4), 313–321.
- Patil, S.D., Rhodes, D.G., and Burgess, D.J., 2005. DNA-based therapeutics and DNA delivery systems: a comprehensive review. The AAPS journal, 7 (1), E61–E77.
- Perrie, Y., et al., 2016. Designing liposomal adjuvants for the next generation of vaccines. Advanced drug delivery reviews, 99 (Pt A), 85–96.
- Pippa, N., Pispas, S., and Demetzos, C., 2012. The delineation of the morphology of charged liposomal vectors via a fractal analysis in aqueous and biological media: physicochemical and self-assembly studies. International journal of pharmaceutics, 437 (1–2), 264–274.
- Pippa, N., Pispas, S., and Demetzos, C., 2016. Physico-chemical characterization and basic research principles of advanced drug delivery nanosystems. Intelligent nanomaterials. Chapter 5, Advanced Materials Book series. Wiley; 107–126.
- Pippa, N., et al., 2013. The shape/morphology balance: a study of stealth liposomes via fractal analysis and drug encapsulation. Pharmaceutical research, 30 (9), 2385–2395.
- Sabin, J., et al., 2006. Size and stability of liposomes: a possible role of hydration and osmotic forces. The European physical journal. E, soft matter, 20 (4), 401–408.
- Semple, S.C., Chonn, Α., and Cullis, P.R., 1998. Interactions of liposomes and lipid-based carrier systems with blood proteins: relation to clearance behaviour in vivo. Advanced drug delivery reviews, 32 (1–2), 3–17.
- Soema, P.C., et al., 2015. Predicting the influence of liposomal lipid composition on liposome size, zeta potential and liposome-induced dendritic cell maturation using a design of experiments approach. European journal of pharmaceutics and biopharmaceutics, 94, 427–435.
- Tardi, P., Leon Wan, C.P., and Maye, L., 2016. Passive and semi-active targeting of bone marrow and leukemia cells using anionic low cholesterol liposomes. Journal of drug targeting, 24 (9), 797–804.
- Vincent, M.P., et al., 2021. Surface chemistry-mediated modulation of adsorbed albumin folding state specifies nanocarrier clearance by distinct macrophage subsets. Nature communications, 12 (1), 618–648.
- Wang, T., Upponi, J.R., and Torchilin, V.P., 2012. Design of multifunctional non-viral gene vectors to overcome physiological barriers: dilemmas and strategies. International journal of pharmaceutics, 427 (1), 3–20.
- Watson, D.S., Endsley, A.N., and Huang, L., 2012. Design considerations for liposomal vaccines: influence of formulation parameters on antibody and cell-mediated immune responses to liposome associated antigens. Vaccine, 30 (13), 2256–2272.
- Wolfram, J., et al., 2014. Shrinkage of pegylated and non-pegylated liposomes in serum. Colloids and surfaces. B, biointerfaces, 114, 294–300.
- Wolfram, J., et al., 2014. The nano-plasma interface: implications of the protein corona. Colloids and surfaces. B, biointerfaces, 124, 17–24.
- Xia, Y., Tian, J., and Chen, X., 2016. Effect of surface properties on liposomal siRNA delivery. Biomaterials, 79, 56–68.
- Yokouchi, Y., et al., 2001. Effect of adsorption of bovine serum albumin on liposomal membrane characteristics. Colloids and surfaces. B, biointerfaces, 20 (2), 95–103.
- Zhang, Y., et al., 2021. Layer-by-layer coated nanoliposomes for oral delivery of insulin. Nanoscale, 13 (2), 776–789.
- Zhao, L., and Feng, S., 2004. Effects of lipid chain length on molecular interactions between paclitaxel and phospholipid within model biomembranes. Journal of colloid and interface science, 274 (1), 55–68.